vs

Side-by-side financial comparison of BCB BANCORP INC (BCBP) and RxSight, Inc. (RXST). Click either name above to swap in a different company.

RxSight, Inc. is the larger business by last-quarter revenue ($32.6M vs $26.2M, roughly 1.2× BCB BANCORP INC). RxSight, Inc. runs the higher net margin — -28.1% vs -49.7%, a 21.6% gap on every dollar of revenue. On growth, BCB BANCORP INC posted the faster year-over-year revenue change (13.1% vs -18.9%). BCB BANCORP INC produced more free cash flow last quarter ($34.9M vs $-2.3M). Over the past eight quarters, RxSight, Inc.'s revenue compounded faster (5.1% CAGR vs 1.8%).

RxSight, Inc. is a medical technology company focused on developing and commercializing innovative intraocular lens solutions for patients undergoing cataract and refractive lens exchange procedures. Its flagship Light Adjustable Lens allows post-surgery power adjustment via a dedicated light delivery device, serving global ophthalmology care markets to improve post-operative visual outcomes for patients.

BCBP vs RXST — Head-to-Head

Bigger by revenue
RXST
RXST
1.2× larger
RXST
$32.6M
$26.2M
BCBP
Growing faster (revenue YoY)
BCBP
BCBP
+32.0% gap
BCBP
13.1%
-18.9%
RXST
Higher net margin
RXST
RXST
21.6% more per $
RXST
-28.1%
-49.7%
BCBP
More free cash flow
BCBP
BCBP
$37.1M more FCF
BCBP
$34.9M
$-2.3M
RXST
Faster 2-yr revenue CAGR
RXST
RXST
Annualised
RXST
5.1%
1.8%
BCBP

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
BCBP
BCBP
RXST
RXST
Revenue
$26.2M
$32.6M
Net Profit
$-12.0M
$-9.2M
Gross Margin
77.5%
Operating Margin
-71.9%
-34.8%
Net Margin
-49.7%
-28.1%
Revenue YoY
13.1%
-18.9%
Net Profit YoY
-467.6%
-54.1%
EPS (diluted)
$-0.73
$-0.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
BCBP
BCBP
RXST
RXST
Q4 25
$26.2M
$32.6M
Q3 25
$26.5M
$30.3M
Q2 25
$25.2M
$33.6M
Q1 25
$23.8M
$37.9M
Q4 24
$23.1M
$40.2M
Q3 24
$26.2M
$35.3M
Q2 24
$20.4M
$34.9M
Q1 24
$25.3M
$29.5M
Net Profit
BCBP
BCBP
RXST
RXST
Q4 25
$-12.0M
$-9.2M
Q3 25
$4.3M
$-9.8M
Q2 25
$3.6M
$-11.8M
Q1 25
$-8.3M
$-8.2M
Q4 24
$3.3M
$-5.9M
Q3 24
$6.7M
$-6.3M
Q2 24
$2.8M
$-6.1M
Q1 24
$5.9M
$-9.1M
Gross Margin
BCBP
BCBP
RXST
RXST
Q4 25
77.5%
Q3 25
79.9%
Q2 25
74.9%
Q1 25
74.8%
Q4 24
71.6%
Q3 24
71.4%
Q2 24
69.5%
Q1 24
70.1%
Operating Margin
BCBP
BCBP
RXST
RXST
Q4 25
-71.9%
-34.8%
Q3 25
21.9%
-40.1%
Q2 25
19.9%
-41.6%
Q1 25
-49.2%
-28.2%
Q4 24
19.9%
-21.5%
Q3 24
35.7%
-26.1%
Q2 24
19.5%
-23.9%
Q1 24
33.0%
-36.2%
Net Margin
BCBP
BCBP
RXST
RXST
Q4 25
-49.7%
-28.1%
Q3 25
16.1%
-32.4%
Q2 25
14.2%
-35.0%
Q1 25
-35.0%
-21.6%
Q4 24
14.1%
-14.8%
Q3 24
25.5%
-17.9%
Q2 24
13.8%
-17.4%
Q1 24
23.2%
-30.8%
EPS (diluted)
BCBP
BCBP
RXST
RXST
Q4 25
$-0.73
$-0.22
Q3 25
$0.22
$-0.24
Q2 25
$0.18
$-0.29
Q1 25
$-0.51
$-0.20
Q4 24
$0.17
$-0.14
Q3 24
$0.36
$-0.16
Q2 24
$0.14
$-0.16
Q1 24
$0.32
$-0.25

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
BCBP
BCBP
RXST
RXST
Cash + ST InvestmentsLiquidity on hand
$228.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$304.3M
$275.7M
Total Assets
$3.3B
$311.8M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
BCBP
BCBP
RXST
RXST
Q4 25
$228.1M
Q3 25
$227.5M
Q2 25
$227.5M
Q1 25
$229.3M
Q4 24
$237.2M
Q3 24
$237.1M
Q2 24
$233.3M
Q1 24
$125.4M
Stockholders' Equity
BCBP
BCBP
RXST
RXST
Q4 25
$304.3M
$275.7M
Q3 25
$318.5M
$276.0M
Q2 25
$315.7M
$278.0M
Q1 25
$314.7M
$279.3M
Q4 24
$323.9M
$281.2M
Q3 24
$328.1M
$277.3M
Q2 24
$320.7M
$275.2M
Q1 24
$320.1M
$163.9M
Total Assets
BCBP
BCBP
RXST
RXST
Q4 25
$3.3B
$311.8M
Q3 25
$3.4B
$308.5M
Q2 25
$3.4B
$309.0M
Q1 25
$3.5B
$313.0M
Q4 24
$3.6B
$318.6M
Q3 24
$3.6B
$310.5M
Q2 24
$3.8B
$305.5M
Q1 24
$3.8B
$183.2M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
BCBP
BCBP
RXST
RXST
Operating Cash FlowLast quarter
$35.9M
$-1.1M
Free Cash FlowOCF − Capex
$34.9M
$-2.3M
FCF MarginFCF / Revenue
133.3%
-6.9%
Capex IntensityCapex / Revenue
4.0%
3.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$58.2M
$-19.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
BCBP
BCBP
RXST
RXST
Q4 25
$35.9M
$-1.1M
Q3 25
$8.7M
$-1.2M
Q2 25
$10.3M
$-4.4M
Q1 25
$5.0M
$-8.8M
Q4 24
$67.7M
$-4.3M
Q3 24
$43.5M
$650.0K
Q2 24
$8.1M
$-4.0M
Q1 24
$8.3M
$-9.3M
Free Cash Flow
BCBP
BCBP
RXST
RXST
Q4 25
$34.9M
$-2.3M
Q3 25
$8.5M
$-1.8M
Q2 25
$10.2M
$-5.9M
Q1 25
$4.7M
$-9.4M
Q4 24
$66.5M
$-5.1M
Q3 24
$43.4M
$-453.0K
Q2 24
$8.1M
$-5.5M
Q1 24
$8.1M
$-11.3M
FCF Margin
BCBP
BCBP
RXST
RXST
Q4 25
133.3%
-6.9%
Q3 25
32.0%
-5.8%
Q2 25
40.4%
-17.6%
Q1 25
19.8%
-24.8%
Q4 24
287.5%
-12.7%
Q3 24
166.0%
-1.3%
Q2 24
39.6%
-15.9%
Q1 24
32.3%
-38.2%
Capex Intensity
BCBP
BCBP
RXST
RXST
Q4 25
4.0%
3.5%
Q3 25
1.1%
1.9%
Q2 25
0.6%
4.6%
Q1 25
1.2%
1.5%
Q4 24
5.3%
2.1%
Q3 24
0.3%
3.1%
Q2 24
0.2%
4.4%
Q1 24
0.6%
6.7%
Cash Conversion
BCBP
BCBP
RXST
RXST
Q4 25
Q3 25
2.05×
Q2 25
2.90×
Q1 25
Q4 24
20.70×
Q3 24
6.53×
Q2 24
2.88×
Q1 24
1.41×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

BCBP
BCBP

Segment breakdown not available.

RXST
RXST

Rxlal$28.2M86%
LDD$3.0M9%
Service Warranty Service Contracts And Accessories$1.5M4%

Related Comparisons